The vulnerability of humankind to SARS-CoV-2 in the absence of a pre-existing immunity,
the unpredictability of the infection outcome, and the high transmissibility, broad tissue …

Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …

The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …

Abstract Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by a
newly identified coronavirus called the severe acute respiratory syndrome-coronavirus 2 …

COVID-19 is a severe respiratory illness that has emerged as a devasting health problem
worldwide. The disease outcome is heterogeneous, which is most likely dependent on the …

To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19
and the current standard care relies on supportive treatments. Therefore, based on the fast …

The newly emerged coronavirus (severe acute respiratory syndrome coronavirus 2 SARS-
CoV-2) and the disease that it causes coronavirus disease 2019 (COVID-19) have changed …

An efficient host immune response is crucial in controlling viral infections. Despite most
studies focused on the implication of T and B cell response in COVID-19 (Corona Virus …

Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) directly interacts
with host's epithelial and immune cells, leading to inflammatory response induction, which is …

The introduction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the
human population represents a tremendous medical and economic crisis. Innate immunity …